logo-loader
viewPharmaCielo

Full interview: PharmaCielo looking to 2020 as a transformative year for the cannabis company

PharmaCielo (CVE: PCLO) Chief Corporate Officer David Gordon joined Steve Darling from Proactive in Toronto to talk about the cannabis company whose operations are in Colombia. Gordon talked about the facilities they have and the advantages the climate in Colombia has for growing. 

Gordon also told Proactive about two key deal recently, One with Creso Pharma and General Extract.

Quick facts: PharmaCielo

Price: 0.98 CAD

TSX-V:PCLO
Market: TSX-V
Market Cap: $97.17 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Xpediator’s 'solid pandemic plan' to see company much stronger on other side

Xpediator (LON:XPD) chief financial officer Robert Ross joins Steve Darling from Proactive ahead of its AGM. Ross talks about its pandemic management plan, its pipeline of acquisition opportunities and how financially secure the company is.

12 minutes ago

2 min read